Both approaches support antioxidative status through different mechanisms.* Who may benefit most from L-Glutathione Power
Semax a heptapeptide with documented BDNF induction, contrasting neurotrophic routes
Presented for research literature review only Li NQ et al
What It Targets Our AOD-9604 peptides are designed to target: Stubborn body fat and slow fat loss in clients already working on nutrition, steps, and strength training. Mild to moderate central adiposity where clients want incremental support rather than a primary weight-loss medication. Clients who cannot or do not wish to use GLP1s but still want to explore peptide-based metabolic support under a transparent riskbenefit discussion. Aesthetic-focused body recomposition journeys where even small improvements in fatmuscle balance can enhance contouring results
Studies have shown that CJC-1295, Ipamorelin, and Tesamorelin significantly increase GH and IGF-1 levels in both men and women
In addition, oral glutathione supplements have been linked to digestive distress, including abdominal cramps or bloating
